{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:38:35Z","timestamp":1792715915701,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"General Guidance Project of Health Science and Technology in Guangzhou","award":["20231A011082"],"award-info":[{"award-number":["20231A011082"]}]},{"name":"Independent Project of the State Key Laboratory of Respiratory Diseases","award":["SKLRD-Z-202305"],"award-info":[{"award-number":["SKLRD-Z-202305"]}]},{"name":"Research Startup Foundation of the Third Affiliated Hospital of Zhengzhou University","award":["BS20220101"],"award-info":[{"award-number":["BS20220101"]}]},{"name":"the Shenzhen Science and Technology Program","award":["JCYJ20210324122401003"],"award-info":[{"award-number":["JCYJ20210324122401003"]}]},{"name":"National Natural Science Foundation of China","award":["82370148"],"award-info":[{"award-number":["82370148"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Krebs Von den Lungen-6 (KL-6) is an established biomarker for interstitial lung diseases (ILDs), but the utility of exosomal KL-6 versus plasma KL-6 in connective tissue disease-associated ILD (CTD-ILD) remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We integrated single-cell transcriptomic re-analysis (GSE135893) with a multi-center cohort of 223 subjects, including 167 ILD, 22 CTD without ILD[CTD (Non-ILD)], 34 healthy controls(HCs). Plasma and exosomal KL-6 were measured, and diagnostic performance was evaluated via Receiver operating characteristic(ROC) analysis. Ten progressive ILD patients were monitored longitudinally.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Single-cell sequencing revealed a significantly stronger correlation between Mucin 1 (MUC1)and exosomal markers (CD63\/CD81) in alveolar type II cells from ILD patients compared to HCs, suggesting a potential vesicular association of KL-6. Clinical validation demonstrated that both plasma and exosomal KL-6 levels were significantly elevated in the ILD group. Crucially, for distinguishing CTD-ILD patients with negative plasma KL-6 results [CTD-ILD (plasma KL-6-)] from HCs, exosomal KL-6 [Area under the curve(AUC)\u2009=\u20090.900] outperformed plasma KL-6 (AUC\u2009=\u20090.879). More importantly, in differentiating CTD-ILD (plasma KL-6-) from CTD (Non-ILD), exosomal KL-6 again showed superior diagnostic accuracy (AUC\u2009=\u20090.782, sensitivity\u2009=\u200990.0%, specificity\u2009=\u200977.3%) compared to plasma KL-6 (AUC\u2009=\u20090.705, sensitivity\u2009=\u200965.0%, specificity\u2009=\u200981.8%). Plasma and exosomal KL-6 concentrations were highly correlated (rs\u2009=\u20090.968,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). In longitudinal monitoring, both biomarkers increased in patients with radiographic disease progression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Exosomal KL-6 is superior to plasma KL-6 for diagnosing CTD-ILD, especially in plasma KL-6-negative patients, and shows potential for monitoring disease progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-026-03816-x","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:39:32Z","timestamp":1785220772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exosomal KL-6 surpasses total plasma KL-6 in the diagnosis of Interstitial Lung Disease (ILD)"],"prefix":"10.1186","volume":"27","author":[{"given":"Huimin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruogu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuilian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoqing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"3816_CR1","doi-asserted-by":"crossref","unstructured":"Mackintosh JA, Wells AU, Cottin V, Nicholson AG, Renzoni EA. Interstitial pneumonia with autoimmune features: challenges and controversies. Eur Respir Rev. 2021;30:210177.","DOI":"10.1183\/16000617.0177-2021"},{"key":"3816_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41379-021-00889-5","volume":"35","author":"ML Smith","year":"2022","unstructured":"Smith ML. The histologic diagnosis of usual interstitial pneumonia of idiopathic pulmonary fibrosis. Where we are and where we need to go. Mod Pathol. 2022;35:8\u201314.","journal-title":"Mod Pathol"},{"key":"3816_CR3","doi-asserted-by":"crossref","unstructured":"Cerro Chiang G, Parimon T. Understanding Interstitial Lung Diseases Associated with Connective Tissue Disease (CTD-ILD): Genetics, Cellular Pathophysiology, and Biologic Drivers. Int J Mol Sci. 2023;24:2405.","DOI":"10.3390\/ijms24032405"},{"key":"3816_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.rmed.2018.02.024","volume":"137","author":"K Yoshimura","year":"2018","unstructured":"Yoshimura K, Kono M, Enomoto Y, Nishimoto K, Oyama Y, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, et al. Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia. Respir Med. 2018;137:167\u201375.","journal-title":"Respir Med"},{"key":"3816_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.31138\/mjr.31.3.330","volume":"31","author":"M Karampeli","year":"2020","unstructured":"Karampeli M, Thomas K, Flouda S, Chavatza A, Nikolopoulos D, Pieta A, Tseronis D, Aggelakos M, Kassara D, Tzavara V, et al. Interstitial Pneumonia with Autoimmune Features (IPAF): A Single-Centre, Prospective Study. Mediterr J Rheumatol. 2020;31:330\u20136.","journal-title":"Mediterr J Rheumatol"},{"key":"3816_CR6","first-page":"203","volume":"18","author":"N Kohno","year":"1988","unstructured":"Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol. 1988;18:203\u201316.","journal-title":"Jpn J Clin Oncol"},{"key":"3816_CR7","first-page":"102673","volume":"69","author":"TD Suryananda","year":"2021","unstructured":"Suryananda TD, Yudhawati R. Association of serum KL-6 levels on COVID-19 severity: A cross-sectional study design with purposive sampling. Ann Med Surg (Lond). 2021;69:102673.","journal-title":"Ann Med Surg (Lond)"},{"key":"3816_CR8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s00795-007-0382-7","volume":"40","author":"Y Ohtsuki","year":"2007","unstructured":"Ohtsuki Y, Fujita J, Hachisuka Y, Uomoto M, Okada Y, Yoshinouchi T, Lee GH, Furihata M, Kohno N. Immunohistochemical and immunoelectron microscopic studies of the localization of KL-6 and epithelial membrane antigen (EMA) in presumably normal pulmonary tissue and in interstitial pneumonia. Med Mol Morphol. 2007;40:198\u2013202.","journal-title":"Med Mol Morphol"},{"key":"3816_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cca.2013.06.002","volume":"424","author":"M Shigemura","year":"2013","unstructured":"Shigemura M, Konno S, Nasuhara Y, Shijubo N, Shimizu C, Nishimura M. Serum KL-6 concentrations are associated with molecular sizes and efflux behavior of KL-6\/MUC1 in healthy subjects. Clin Chim Acta. 2013;424:148\u201352.","journal-title":"Clin Chim Acta"},{"key":"3816_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.resinv.2012.02.001","volume":"50","author":"N Ishikawa","year":"2012","unstructured":"Ishikawa N, Hattori N, Yokoyama A, Kohno N. Utility of KL-6\/MUC1 in the clinical management of interstitial lung diseases. Respir Investig. 2012;50:3\u201313.","journal-title":"Respir Investig"},{"key":"3816_CR11","doi-asserted-by":"publisher","first-page":"F135","DOI":"10.1152\/ajprenal.00127.2021","volume":"321","author":"MM Al-Bataineh","year":"2021","unstructured":"Al-Bataineh MM, Kinlough CL, Mi Z, Jackson EK, Mutchler SM, Emlet DR, Kellum JA, Hughey RP. KIM-1-mediated anti-inflammatory activity is preserved by MUC1 induction in the proximal tubule during ischemia-reperfusion injury. Am J Physiol Ren Physiol. 2021;321:F135\u201348.","journal-title":"Am J Physiol Ren Physiol"},{"key":"3816_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1042\/BJ20040513","volume":"382","author":"A Thathiah","year":"2004","unstructured":"Thathiah A, Carson DD. MT1-MMP mediates MUC1 shedding independent of TACE\/ADAM17. Biochem J. 2004;382:363\u201373.","journal-title":"Biochem J"},{"key":"3816_CR13","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/jcb.22292","volume":"108","author":"J Julian","year":"2009","unstructured":"Julian J, Dharmaraj N, Carson DD. MUC1 is a substrate for gamma-secretase. J Cell Biochem. 2009;108:802\u201315.","journal-title":"J Cell Biochem"},{"key":"3816_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1164\/ajrccm.156.1.9612043","volume":"156","author":"Y Inoue","year":"1997","unstructured":"Inoue Y, Barker E, Daniloff E, Kohno N, Hiwada K, Newman LS. Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis. Am J Respir Crit Care Med. 1997;156:109\u201315.","journal-title":"Am J Respir Crit Care Med"},{"key":"3816_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1479-5876-10-111","volume":"10","author":"M Shigemura","year":"2012","unstructured":"Shigemura M, Nasuhara Y, Konno S, Shimizu C, Matsuno K, Yamguchi E, Nishimura M. Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis. J Transl Med. 2012;10:111.","journal-title":"J Transl Med"},{"key":"3816_CR16","doi-asserted-by":"publisher","first-page":"22725","DOI":"10.1038\/s41598-021-02242-x","volume":"11","author":"AC Verceles","year":"2021","unstructured":"Verceles AC, Bhat P, Nagaria Z, Martin D, Patel H, Ntem-Mensah A, Hyun SW, Hahn A, Jeudy J, Cross AS, et al. MUC1 ectodomain is a flagellin-targeting decoy receptor and biomarker operative during Pseudomonas aeruginosa lung infection. Sci Rep. 2021;11:22725.","journal-title":"Sci Rep"},{"key":"3816_CR17","doi-asserted-by":"publisher","first-page":"e19493","DOI":"10.1097\/MD.0000000000019493","volume":"99","author":"H Zhang","year":"2020","unstructured":"Zhang H, Chen L, Wu L, Huang J, Li H, Wang X, Weng H. Diagnostic and prognostic predictive values of circulating KL-6 for interstitial lung disease: A PRISMA-compliant systematic review and meta-analysis. Med (Baltim). 2020;99:e19493.","journal-title":"Med (Baltim)"},{"key":"3816_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/crj.12341","volume":"11","author":"Y Hu","year":"2017","unstructured":"Hu Y, Wang LS, Jin YP, Du SS, Du YK, He X, Weng D, Zhou Y, Li QH, Shen L, et al. Serum Krebs von den Lungen-6 level as a diagnostic biomarker for interstitial lung disease in Chinese patients. Clin Respir J. 2017;11:337\u201345.","journal-title":"Clin Respir J"},{"key":"3816_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19:213\u201328.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3816_CR20","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.7150\/jca.48531","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen Z, Liang Q, Zeng H, Zhao Q, Guo Z, Zhong R, Xie M, Cai X, Su J, He Z, et al. Exosomal CA125 as A Promising Biomarker for Ovarian Cancer Diagnosis. J Cancer. 2020;11:6445\u201353.","journal-title":"J Cancer"},{"key":"3816_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13048-023-01336-6","volume":"17","author":"H Shi","year":"2024","unstructured":"Shi H, Liu L, Deng X, Xing X, Zhang Y, Djouda Rebecca Y, Han L. Exosomal biomarkers in the differential diagnosis of ovarian tumors: the emerging roles of CA125, HE4, and C5a. J Ovarian Res. 2024;17:4.","journal-title":"J Ovarian Res"},{"key":"3816_CR22","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(22)01052-2","volume":"400","author":"M Wijsenbeek","year":"2022","unstructured":"Wijsenbeek M, Suzuki A, Maher TM. Interstitial lung diseases. Lancet. 2022;400:769\u201386.","journal-title":"Lancet"},{"key":"3816_CR23","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, Kreuter M, Lynch DA, Maher TM, Martinez FJ, et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022;205:e18\u201347.","journal-title":"Am J Respir Crit Care Med"},{"key":"3816_CR24","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(12)61079-4","volume":"380","author":"A Fischer","year":"2012","unstructured":"Fischer A, du Bois R. Interstitial lung disease in connective tissue disorders. Lancet. 2012;380:689\u201398.","journal-title":"Lancet"},{"key":"3816_CR25","doi-asserted-by":"publisher","first-page":"2402533","DOI":"10.1183\/13993003.02533-2024","volume":"67","author":"KM Antoniou","year":"2026","unstructured":"Antoniou KM, Distler O, Gheorghiu A-M, Moor CC, Vikse J, Bizymi N, Galetti I, Brown G, Bargagli E, Allanore Y, et al. ERS\/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease. Eur Respir J. 2026;67:2402533.","journal-title":"Eur Respir J"},{"key":"3816_CR26","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.40320","volume":"69","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, et al. 2017 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups. Arthritis Rheumatol. 2017;69:2271\u201382.","journal-title":"Arthritis Rheumatol"},{"key":"3816_CR27","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580\u20138.","journal-title":"Ann Rheum Dis"},{"key":"3816_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X. 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76:9\u201316.","journal-title":"Ann Rheum Dis"},{"key":"3816_CR29","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr., Carreira PE, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737\u201347.","journal-title":"Arthritis Rheum"},{"key":"3816_CR30","doi-asserted-by":"publisher","first-page":"9692030","DOI":"10.1155\/2020\/9692030","volume":"2020","author":"KJ John","year":"2020","unstructured":"John KJ, Sadiq M, George T, Gunasekaran K, Francis N, Rajadurai E, Sudarsanam TD. Clinical and Immunological Profile of Mixed Connective Tissue Disease and a Comparison of Four Diagnostic Criteria. Int J Rheumatol. 2020;2020:9692030.","journal-title":"Int J Rheumatol"},{"key":"3816_CR31","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41592-020-01034-x","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zhu Q, Cheng L, Wang Y, Li M, Yang Q, Hu L, Lou D, Li J, Dong X, et al. Exosome detection via the ultrafast-isolation system: EXODUS. Nat Methods. 2021;18:212\u20138.","journal-title":"Nat Methods"},{"key":"3816_CR32","first-page":"653","volume":"44","author":"J Kobayashi","year":"1996","unstructured":"Kobayashi J, Itoh Y, Kitamura S, Kawai T. [Establishment of reference intervals and cut-off value by an enzyme immunoassay for KL-6 antigen, a new marker for interstitial pneumonia]. Rinsho Byori. 1996;44:653\u20138.","journal-title":"Rinsho Byori"},{"key":"3816_CR33","doi-asserted-by":"publisher","first-page":"eaba1972","DOI":"10.1126\/sciadv.aba1972","volume":"6","author":"AC Habermann","year":"2020","unstructured":"Habermann AC, Gutierrez AJ, Bui LT, Yahn SL, Winters NI, Calvi CL, Peter L, Chung MI, Taylor CJ, Jetter C, et al. Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis. Sci Adv. 2020;6:eaba1972.","journal-title":"Sci Adv"},{"key":"3816_CR34","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S2213-2600(21)00503-8","volume":"10","author":"WS Bowman","year":"2022","unstructured":"Bowman WS, Newton CA, Linderholm AL, Neely ML, Pugashetti JV, Kaul B, Vo V, Echt GA, Leon W, Shah RJ, et al. Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis. Lancet Respir Med. 2022;10:593\u2013602.","journal-title":"Lancet Respir Med"},{"key":"3816_CR35","doi-asserted-by":"publisher","first-page":"1146904","DOI":"10.3389\/fimmu.2023.1146904","volume":"14","author":"Y Wu","year":"2023","unstructured":"Wu Y, Li Y, Luo Y, Zhou Y, Liang X, Cheng L, Wu T, Wen J, Tan C, Liu Y. Proteomics: Potential techniques for discovering the pathogenesis of connective tissue diseases-interstitial lung disease. Front Immunol. 2023;14:1146904.","journal-title":"Front Immunol"},{"key":"3816_CR36","doi-asserted-by":"crossref","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977.","DOI":"10.1126\/science.aau6977"},{"key":"3816_CR37","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1136\/thoraxjnl-2020-216370","volume":"76","author":"A Trappe","year":"2021","unstructured":"Trappe A, Donnelly SC, McNally P, Coppinger JA. Role of extracellular vesicles in chronic lung disease. Thorax. 2021;76:1047\u201356.","journal-title":"Thorax"},{"key":"3816_CR38","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1038\/s41467-021-24384-2","volume":"12","author":"M Mathieu","year":"2021","unstructured":"Mathieu M, Nevo N, Jouve M, Valenzuela JI, Maurin M, Verweij FJ, Palmulli R, Lankar D, Dingli F, Loew D, et al. Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9. Nat Commun. 2021;12:4389.","journal-title":"Nat Commun"},{"key":"3816_CR39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.redox.2018.06.009","volume":"18","author":"KP Hough","year":"2018","unstructured":"Hough KP, Trevor JL, Strenkowski JG, Wang Y, Chacko BK, Tousif S, Chanda D, Steele C, Antony VB, Dokland T, et al. Exosomal transfer of mitochondria from airway myeloid-derived regulatory cells to T cells. Redox Biol. 2018;18:54\u201364.","journal-title":"Redox Biol"},{"key":"3816_CR40","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12967-016-1056-9","volume":"14","author":"Z Wang","year":"2016","unstructured":"Wang Z, Chen JQ, Liu JL, Tian L. Exosomes in tumor microenvironment: novel transporters and biomarkers. J Transl Med. 2016;14:297.","journal-title":"J Transl Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03816-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03816-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03816-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:48:44Z","timestamp":1792712924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03816-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3816"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03816-x","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committees of the First Affiliated Hospital of Guangzhou Medical University (Approval number: ES-2023-207-03), the Second Affiliated Hospital of Guangzhou Medical University (Approval number: 2024-hs-29), and Dongguan People's Hospital (Approval number: KYKT2024-058). The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"418"}}